The retatrutide availability timeline depends on ongoing clinical trials and regulatory review: Current status: Multiple phase 3 trials (TRIUMPH program) ongoing Phase 3 primary completion: Expected through mid-year NDA submission: Eli Lilly expected to submit to FDA in late future FDA review period: Approximately 10 months after submission Estimated approval: Potentially late next year at earliest Commercial launch: Could follow shortly after approval It is important to note that Eli Lilly has not announced an official filing timeline
Medications shipped to your home If prescribed, your prescription will be delivered to your doorstep with clear instructions based on your prescribed format (injection or pill)
This enzymatic action depletes the available intracellular pool of nicotinamide, directly limiting the synthesis of nicotinamide adenine dinucleotide (NAD+)
Finally, it applies a 10%, 12.5%, or 15% deficit to your TDEE to give you a daily calorie target
Through strict quality control, independent testing, and transparent sourcing, we help advance scientific research reliably and responsibly.
